| Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy T Nakayama, Y Sugano, T Yokokawa, T Nagai, T Matsuyama, ... European Journal of Heart Failure 19 (4), 490-498, 2017 | 79 | 2017 |
| Significance of myocardial tenascin‐C expression in left ventricular remodelling and long‐term outcome in patients with dilated cardiomyopathy T Yokokawa, Y Sugano, T Nakayama, T Nagai, T Matsuyama, ... European Journal of Heart Failure 18 (4), 375-385, 2016 | 48 | 2016 |
| A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity T Yokokawa, Y Sugano, A Shimouchi, A Shibata, T Nakayama, T Ohara, ... International journal of cardiology 204, 112-113, 2016 | 17 | 2016 |
| Dilated cardiomyopathy with eosinophilic granulomatosis with polyangiitis in which active myocardial inflammation was only detected by endomyocardial biopsy T Nakayama, S Murai, N Ohte Internal Medicine 57 (18), 2675-2679, 2018 | 9 | 2018 |
| Physical activity and mortality in older patients with a pacemaker T Goto, K Mori, K Nakasuka, M Kato, T Nakayama, T Banno, T Ichihashi, ... Geriatrics & Gerontology International 20 (2), 106-111, 2020 | 8 | 2020 |
| Myocardial T-Lymphocytes as a Prognostic Risk-Stratifying Marker of Dilated Cardiomyopathy―Results of the Multicenter Registry to Investigate Inflammatory Cell Infiltration in … K Ohta-Ogo, Y Sugano, S Ogata, T Nakayama, T Komori, K Eguchi, ... Circulation Journal 86 (7), 1092-1101, 2022 | 7 | 2022 |
| Unusual interventional treatment of spontaneous coronary artery dissection without stent implantation: a case series H Fujita, M Yokoi, T Ito, T Nakayama, Y Shintani, T Sugiura, Y Seo, N Ohte European Heart Journal-Case Reports 5 (8), ytab306, 2021 | 5 | 2021 |
| Impact of glucose variability on coronary plaque vulnerability in patients with dysglycemia: a whole coronary analysis with multislice computed tomography T Ito, K Nakasuka, H Fujita, M Yokoi, T Nakayama, T Sugiura, N Ohte, ... Journal of Cardiology 79 (1), 58-64, 2022 | 4 | 2022 |
| Effects of hemodialysis and reduced estimated glomerular filtration rate in nonhemodialysis on clinical outcomes after fractional flow reserve-guided deferral of revascularization M Yokoi, T Ito, T Nakayama, H Fujita, T Sugiura, Y Seo Medicine 101 (20), e29256, 2022 | 3 | 2022 |
| Multimorbidity, polypharmacy, and mortality in older patients with pacemakers T Goto, K Mori, T Nakayama, J Yamamoto, Y Shintani, K Wakami, ... Journal of Arrhythmia 38 (1), 145-154, 2022 | 3 | 2022 |
| Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial S Ito, H Takahama, M Asakura, Y Abe, M Ajioka, T Anzai, T Arikawa, ... Scientific reports 13 (1), 12517, 2023 | 2 | 2023 |
| Ventricular sigmoid septum as a risk factor for anthracycline-induced cancer therapeutics-related cardiac dysfunction in patients with malignant lymphoma T Nakayama, Y Oshima, Y Shintani, J Yamamoto, M Yokoi, T Ito, ... Circulation Reports 4 (4), 173-182, 2022 | 2 | 2022 |
| Impact of left ventricular hypertrophy on clinical outcomes in patients with dialysis: A single-center study in Japan T Nakayama, J Yamamoto, T Ozeki, K Yasuda, C Yamazaki, T Ito, T Goto, ... Journal of Medical Ultrasonics 49 (2), 241-252, 2022 | 2 | 2022 |
| Cardiac β-adrenergic receptor downregulation, evaluated by cardiac PET, in chronotropic incompetence T Goto, S Kikuchi, K Mori, T Nakayama, H Fukuta, Y Seo, H Narita, A Iida, ... Journal of Nuclear Medicine 62 (7), 996-998, 2021 | 2 | 2021 |
| Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center … T Nakayama, Y Oshima, S Kusumoto, J Yamamoto, S Osaga, H Fujinami, ... EJHaem 1 (2), 498-506, 2020 | 2 | 2020 |
| A successful case of percutaneous fistula closure in a patient with high output heart failure and extracardiac arteriovenous fistula Y Kato, T Nakayama, J Yamamoto, K Muto, S Kitada, K Suzuki, ... Journal of Cardiology Cases 19 (4), 125-128, 2019 | 2 | 2019 |
| Hemodialysis-induced myocardial stunning with no obstructive coronary artery disease: Pathophysiological significance of coronary microvascular dysfunction M Yokoi, T Ito, W Suzuki, J Yamamoto, T Nakayama, T Ichihashi, ... Internal Medicine, 2388-23, 2024 | 1 | 2024 |
| Clinical impact of the pathological quantification of myocardial fibrosis and infiltrating T lymphocytes using an endomyocardial biopsy in patients with hypertrophic cardiomyopathy Y Shintani, T Nakayama, A Masaki, M Yokoi, K Wakami, T Ito, T Goto, ... International Journal of Cardiology 362, 110-117, 2022 | 1 | 2022 |
| Clinical features, risk factors, and prognosis of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP like regimen T Nakayama, Y Oshima, S Kusumoto, S Osaga, J Yamamoto, K Wakami, ... European Heart Journal 41 (Supplement_2), ehaa946. 2039, 2020 | 1 | 2020 |
| Feasibility of transcatheter prosthetic paravalvular leakage closure: a single-center, exploratory safety evaluation study of transcatheter closure of prosthetic paravalvular … T Nakayama, A Okada, T Hasegawa, Y Morita, H Kanzaki, K Yamashita, ... General Thoracic and Cardiovascular Surgery 67, 493-500, 2019 | 1 | 2019 |
